SEATTLE, May 8 /PRNewswire/ -- Amnis Corporation, a manufacturer of advanced
cell imaging systems, today announced the launch of the new ImageStreamX
imaging flow cytometer. The new instrument - the second generation of the
patented ImageStream(R) technology - combines the speed, sensitivity, and
phenotyping abilities of flow cytometry with the detailed imagery and
functional insights of microscopy. The new ImageStreamX greatly expands the
capabilities of the platform with faster sample throughput, more excitation
lasers and detection channels, higher image quality, and greater productivity.
(Photo: http://www.newscom.com/cgi-bin/prnh/20090508/SF14254)
"The ImageStreamX is ten times faster, has better quality imagery, and can now
produce up to 12 images per cell," remarked William Ortyn, Amnis' co-founder
and Chief Operations Officer. "No other cell analysis platform gives you as
much information in a single experiment or allows you to combine detailed
functional and phenotypic studies," added Ortyn.
"The modularity of the new ImageStreamX allows it to fit into a much wider
range of budgets, while its performance characteristics make it much more
competitive against conventional flow cytometry," said David Basiji, Ph.D.,
Amnis' President and Chief Executive Officer.
About Amnis: Amnis Corporation, headquartered in Seattle, WA, develops,
manufactures and markets instrumentation for high speed cell imaging for
research and diagnostic markets. The initial ImageStream system, introduced in
2005, is in service in over 50 labs world-wide and has an excellent track
record of performance and reliability. Researchers have utilized ImageStream
technology to produce over 75 groundbreaking publications and numerous
conference posters and presentations.
SOURCE Amnis Corporation
David Basiji, President and Chief Executive Officer of Amnis Corporation,
+1-206-374-7000, Fax, +1-206-576-6895, info@amnis.com
